Cargando…
Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic
The majority of breast cancers express the estrogen receptor (ER) and for this group of patients, endocrine therapy is the cornerstone of systemic treatment. However, drug resistance is common and a focus for breast cancer preclinical and clinical research. Over the past 2 decades, the PI3K/Akt/mTOR...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Open Exploration
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400772/ https://www.ncbi.nlm.nih.gov/pubmed/36046843 http://dx.doi.org/10.37349/etat.2022.00078 |